These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8809591)

  • 21. Pancreatic endocrine tumors: diagnostic pitfalls.
    Ectors N
    Hepatogastroenterology; 1999; 46(26):679-90. PubMed ID: 10370596
    [No Abstract]   [Full Text] [Related]  

  • 22. [Paraneoplastic endocrine syndromes].
    Domański J
    Wiad Lek; 1989 Aug 15-Sep 15; 42(16-18):956-9. PubMed ID: 2561752
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.
    Wood SM; Kraenzlin ME; Adrian TE; Bloom SR
    Gut; 1985 May; 26(5):438-44. PubMed ID: 2860052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unique case of a nonfunctional metastatic pancreatic neuroendocrine tumor transforming into an insulin-secreting tumor with an unusual clinical course.
    Vashi PG; Gupta D; Dahlk S
    Pancreas; 2011 Jul; 40(5):781-4. PubMed ID: 21673539
    [No Abstract]   [Full Text] [Related]  

  • 25. Different Hormonal Expression Patterns Between Primary Pancreatic Neuroendocrine Tumors and Metastatic Sites.
    Kimura H; Ohtsuka T; Fujimoto T; Date K; Matsunaga T; Cases AI; Abe A; Mizuuchi Y; Miyasaka Y; Ito T; Oda Y; Nakamura M; Tanaka M
    Pancreas; 2016 Aug; 45(7):947-52. PubMed ID: 26684862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
    Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
    Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and diagnosis of alimentary endocrine tumours.
    Welbourn RB
    J Clin Pathol Suppl (Assoc Clin Pathol); 1978; 8():85-91. PubMed ID: 45198
    [No Abstract]   [Full Text] [Related]  

  • 28. Parathyroid hormone-related protein in hypercalcaemia of malignancy.
    Martin TJ; Suva LJ
    Clin Endocrinol (Oxf); 1989 Nov; 31(5):631-47. PubMed ID: 2697477
    [No Abstract]   [Full Text] [Related]  

  • 29. Ectopic acromegaly: localization of the pituitary growth hormone-releasing hormone producing tumor by In-111 pentetreotide scintigraphy and report of two cases.
    Morel O; Giraud P; Bernier MO; Le Jeune JJ; Rohmer V; Jallet P
    Clin Nucl Med; 2004 Dec; 29(12):841-3. PubMed ID: 15545901
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein.
    Wynick D; Ratcliffe WA; Heath DA; Ball S; Barnard M; Bloom SR
    BMJ; 1990 May; 300(6735):1314-5. PubMed ID: 2164430
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: Islets of Langerhans.
    Zollinger RM
    Proc Natl Cancer Conf; 1972; 7():523-7. PubMed ID: 4358065
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bihormonal apudoma of the pancreas].
    Konstantinov GS
    Arkh Patol; 1987; 49(12):62-4. PubMed ID: 3328594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercalcemia due to ectopic secretion of parathyroid related protein from pancreatic carcinoma: a case report.
    Cavestro GM; Mantovani N; Coruzzi P; Nouvenne A; Marcucci F; Franzè A; Di Mario F; Okolicsanyi L
    Acta Biomed; 2002; 73(1-2):37-40. PubMed ID: 12233276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephrotoxic and cytoproliferative effects of streptozotocin: report of a patient with multiple hormone-secreting islet cell carcinoma.
    Myerowitz RL; Sartiano GP; Cavallo T
    Cancer; 1976 Oct; 38(4):1550-5. PubMed ID: 186169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duodeno-pancreatic neuroendocrine tumours.
    Peros G; Sakorafas GH; Konstantoudakis G; Giannopoulos GA; Petropoulou K; Parasi A
    Eur J Cancer Care (Engl); 2010 May; 19(3):393-402. PubMed ID: 19708940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endocrine paraneoplastic syndromes].
    Reisch N; Reincke M
    Internist (Berl); 2018 Feb; 59(2):125-133. PubMed ID: 29387897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant hormone production from ovarian neoplasms: strategies for diagnosis and therapy.
    Leach SD; LaMorte AI; True LD; Flynn SD; Schwartz PE; Cahow CE; Kinder BK
    World J Surg; 1990; 14(3):335-40; discussion 340-1. PubMed ID: 2164282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine paraneoplastic syndromes in lung cancer.
    Mazzone PJ; Arroliga AC
    Curr Opin Pulm Med; 2003 Jul; 9(4):313-20. PubMed ID: 12806246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of functional and nonfunctional neuroendocrine tumors in the pancreas and peripancreatic region.
    Wang SE; Su CH; Kuo YJ; Shyr YM; Li AF; Chen TH; Wu CW; Lee CH
    Pancreas; 2011 Mar; 40(2):253-9. PubMed ID: 20966805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pancreatic tumors with endocrine activity in adolescents].
    Julisová I; Dudorkinová D; Pertlícek J; Slezák Z
    Cesk Pediatr; 1990 May; 45(5):273-5. PubMed ID: 2249292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.